Recruiting OBSERVATIONAL NCT06862934
Liver Transplantation for Unresectable Intrahepatic Colangiocarcinoma After Sustained Response to Neoadjuvant Treatments (iCOLA)
Liver Transplantation for Unresectable Intrahepatic Colangiocarcinoma After Sustained Response to Neoadjuvant Treatments (iCOLA)
Sponsor: Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Conditions
Intrahepatic Cholangiocarcinoma (Icc)
Updated 1 time since 2025 Last updated: Mar 3, 2025 Started: Mar 20, 2025 Primary completion: Dec 31, 2027 Completion: Dec 31, 2027
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.
Listed as NCT06862934, this observational or N/A phase trial focuses on Intrahepatic Cholangiocarcinoma (Icc) and remains actively recruiting participants. Sponsored by Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, it has been updated 1 time since 2025, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.
Status Flow
Change History
1 version recorded Recruiting
[monthly]
Eligibility Summary
No eligibility information available.
Contact Information
Sponsor contact:
- Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Data source: Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
For direct contact, visit the study record on ClinicalTrials.gov .